Concourse Financial Group Securities’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 8559 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 8652 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 8657 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 8667 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 8669 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 8600 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 8390 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 8176 |
|
|
2023
Q1 | – | Sell |
-172
| Closed | -$7.06K | – | 7874 |
|
|
2022
Q4 | $7.06K | Hold |
172
| – | – | ﹤0.01% | 1754 |
|
|
2022
Q3 | $7K | Buy |
172
+1
| +0.6% | +$41 | ﹤0.01% | 1581 |
|
|
2022
Q2 | $7K | Buy |
171
+1
| +0.6% | +$41 | ﹤0.01% | 1779 |
|
|
2022
Q1 | $8K | Hold |
170
| – | – | ﹤0.01% | 1768 |
|
|
2021
Q4 | $8K | Buy |
170
+1
| +0.6% | +$47 | ﹤0.01% | 1936 |
|
|
2021
Q3 | $8K | Hold |
169
| – | – | ﹤0.01% | 1960 |
|
|
2021
Q2 | $9K | Buy |
169
+1
| +0.6% | +$53 | ﹤0.01% | 1908 |
|
|
2021
Q1 | $8K | Hold |
168
| – | – | ﹤0.01% | 1840 |
|
|
2020
Q4 | $9K | Sell |
168
-120
| -42% | -$6.43K | ﹤0.01% | 1733 |
|
|
2020
Q3 | $13K | Hold |
288
| – | – | ﹤0.01% | 1500 |
|
|
2020
Q2 | $12K | Buy |
288
+121
| +72% | +$5.04K | ﹤0.01% | 1442 |
|
|
2020
Q1 | $6K | Hold |
167
| – | – | ﹤0.01% | 1619 |
|
|
2019
Q4 | $8K | Buy |
+167
| New | +$8K | ﹤0.01% | 1511 |
|
|
2019
Q3 | – | Sell |
-260
| Closed | -$10K | – | 5697 |
|
|
2019
Q2 | $10K | Sell |
260
-5,410
| -95% | -$208K | ﹤0.01% | 1503 |
|
|
2019
Q1 | $235K | Buy |
5,670
+5,504
| +3,316% | +$228K | 0.02% | 432 |
|
|
2018
Q4 | $6K | Buy |
+166
| New | +$6K | ﹤0.01% | 1619 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 5369 |
|